Login to Your Account



Pharma: Other News To Note


Monday, May 21, 2012

• Pfizer Inc., of New York, presented reports of studies on Lyrica (pregabalin) at the American Pain Society meeting in Honolulu, including an exploratory study, using functional magnetic resonance imaging (fMRI), showing that Lyrica decreased connectivity between various parts of the brain involved in pain processing in fibromyalgia patients.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription